• Oct 03, 2013 | Webcast

    Therapeutics

    Douglas Kiel, MD, MPH; Denis Guttridge, PhD; Se-Jin Lee, MD, PhD; Ronnen Roubenoff, MD; William Evans, PhD
    Integrative Physiology of the Skeleton

    Chair:
    Douglas Kiel, M.D., M.P.H., Institute for Aging Research, Hebrew SeniorLife

    Speakers:
    Pre-clinical Translation-NFkB
    Denis Guttridge, Ph.D., Ohio State University

    Myostatin
    Se-Jin Lee, M.D., Ph.D., Johns Hopkins University School of Medicine

    Therapeutic Targets for Muscle Wasting
    Ronenn Roubenoff, M.D., Novartis Institutes for Biomedical Research and Tufts University

    Developing New Medicines to Treat Muscle Wasting, Frailty and Sarcopenia
    William Evans, Ph.D., GlaxoSmithKline 

    Supported by an educational grant from Lilly USA, LLC

    Funding for this conference was made possible (in part) by Grant R13AR065905-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    Length: 100 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details